Pasi Korhonen

Summary

Affiliation: Orion Pharma
Country: Finland

Publications

  1. ncbi The Finnish Cancer Registry as follow-up source of a large trial cohort--accuracy and delay
    Pasi Korhonen
    Orion Pharma, Department of Biostatistics and Data Management, Espoo, Finland
    Acta Oncol 41:381-8. 2002
  2. ncbi Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland)
    Nea Malila
    National Public Health Institute, Helsinki, Finland
    Cancer Causes Control 13:617-23. 2002
  3. ncbi Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up
    Jarmo Virtamo
    National Public Health Institute, Helsinki, Finland
    JAMA 290:476-85. 2003
  4. ncbi Flavonol and flavone intake and the risk of intermittent claudication in male smokers
    Tero Hirvonen
    Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland
    Eur J Epidemiol 19:305-11. 2004

Collaborators

Detail Information

Publications4

  1. ncbi The Finnish Cancer Registry as follow-up source of a large trial cohort--accuracy and delay
    Pasi Korhonen
    Orion Pharma, Department of Biostatistics and Data Management, Espoo, Finland
    Acta Oncol 41:381-8. 2002
    ..8% were unknown to the Registry. The accuracy of the FCR data is high but the delay in case notification should be considered in epidemiological studies...
  2. ncbi Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland)
    Nea Malila
    National Public Health Institute, Helsinki, Finland
    Cancer Causes Control 13:617-23. 2002
    ..This study investigated the effects of alpha-tocopherol and beta-carotene supplementation on the incidence of gastric cancer...
  3. ncbi Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up
    Jarmo Virtamo
    National Public Health Institute, Helsinki, Finland
    JAMA 290:476-85. 2003
    ..The preventive effects of alpha-tocopherol on prostate cancer require confirmation in other trials. Smokers should avoid beta-carotene supplementation...
  4. ncbi Flavonol and flavone intake and the risk of intermittent claudication in male smokers
    Tero Hirvonen
    Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland
    Eur J Epidemiol 19:305-11. 2004
    ..63, 95% CI: 0.41-0.98). Adjustment for flavonol and flavone intake only marginally changed these associations. In conclusion, flavonol and flavone intake was not independently associated with the risk of intermittent claudication...